Rigshospitalet removes transplant surgeons, endangering critical cancer care
Rigshospitalet has sent its transplant surgeons home, prompting concerns that the move could jeopardize treatment for the nation’s most vulnerable cancer patients, including children needing complex pancreas procedures.
The decision by Rigshospitalet to dismiss its transplant surgery team has raised alarms among patients and physicians. Both groups warn that the loss of specialist surgeons may severely affect care for the sickest cancer sufferers, especially pediatric cases requiring advanced pancreatic surgery or organ transplantation. The hospital’s action could therefore limit access to life-saving operations for a small but high-risk group.
Why it matters
Loss of transplant surgeons may limit life-saving surgery for the sickest cancer patients, especially children.
In this story
